Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.57 |
| ▸ | HTR2C | P28335 | 1/20 | 0.57 |
| ▸ | HTR2B | P41595 | 1/20 | 0.57 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.55 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.46 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | HTR6 | P50406 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15147096 | 1.00 | HTR2A (0.57) | HTR2AHTR2CHTR2BPDPK1IDO1 | |
| SCHEMBL321745 | 0.86 | IDO1 (0.53) | HTR2AHTR2CHTR2BPDPK1IDO1 | |
| SCHEMBL29977975 | 0.86 | IDO1 (0.53) | HTR2AHTR2CHTR2BPDPK1IDO1 | |
| SCHEMBL15147106 | 0.86 | IDO1 (0.53) | HTR2AHTR2CHTR2BPDPK1IDO1 | |
| SCHEMBL7374844 | 0.85 | HTR2A (0.52) | HTR2AHTR2CHTR2BPDPK1IDO1 | |
| SCHEMBL7898130 | 0.83 | TSHR (0.52) | HTR2AHTR2CHTR2BPDPK1IDO1 | |
| Hydrogen Peroxide SCHEMBL8418801 | 0.83 | IDO1 (0.50) | HTR2AHTR2CHTR2BPDPK1IDO1 | |
| SCHEMBL11875174 | 0.82 | ALDH1A1 (0.44) | HTR2AHTR2CHTR2BPDPK1IDO1 | |
| Methacrylic Acid SCHEMBL1220641 | 0.82 | PIN1 (0.44) | HTR2AHTR2CHTR2BPDPK1CYP11B2 | |
| SCHEMBL6230330 | 0.79 | DRD2 (0.50) | HTR2APDPK1IDO1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 938 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119861156-A | Method for pre-judging identification degree of high molecular material interfering fire scene gasoline inspection | 中国人民警察大学(公安部国际执法合作学院、中国维和警察培训中心) | 2025-04-22 | — | — | CN | claimed |
| CN-117181288-A | Hydrocracking catalyst and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-117181294-A | Diesel oil hydro-upgrading catalyst and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-117181287-A | Hydrogenation catalyst for raw materials rich in bicyclic aromatic hydrocarbon as well as preparation method and application thereof | 中国石油化工股份有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-117181293-A | Hydrogenation catalyst for polycyclic aromatic hydrocarbon-rich raw material, and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-12-08 | — | — | CN | claimed |
| CN-117164420-A | Method for synthesizing methyl indane and tetrahydronaphthalene from cyclopentanone | 中国科学院大连化学物理研究所 | 2023-12-05 | — | — | CN | claimed |
| CN-115990504-A | Layered mordenite catalyst, and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-115991624-A | Method for producing tetratoluene | 中国石油化工股份有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-113278441-B | Auxiliary agent for optimizing product distribution in delayed coking or visbreaking process and preparation method thereof | 山东京博石油化工有限公司 | 2022-11-29 | — | — | CN | claimed |
| US-11377405-B2 | Indene composition | ENEOS CORPORATION (JP) | 2022-07-05 | — | — | US | claimed |
| US-20020058809-A1 | Compounds useful as reversible inhibitors of cysteine proteases | EMMANUEL MICHEL JOSE (US) | 2002-05-16 | — | — | US | claimed |
| EP-1196411-A1 | BRADYKININ B1 RECEPTOR ANTAGONISTS | PHARMACOPEIA, INC. (US) | 2002-04-17 | — | — | EP | claimed |
| WO-2001019816-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2001-03-22 | — | — | WO | claimed |
| WO-2001005783-A1 | BRADYKININ B1 RECEPTOR ANTAGONISTS | PHARMACOPEIA, INC. (US) | 2001-01-25 | — | — | WO | claimed |
| EP-0973768-A1 | AZOLE COMPOUNDS, THEIR PRODUCTION AND THEIR USE | Takeda Chemical Industries, Ltd. (JP) | 2000-01-26 | — | — | EP | claimed |
| WO-1998043970-A1 | AZOLE COMPOUNDS, THEIR PRODUCTION AND THEIR USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-10-08 | — | — | WO | claimed |
| EP-0549245-A1 | Para-xylene adsorptive separation with indan or indan derivatives as heavy desorbent | UOP (US) | 1993-06-30 | — | — | EP | claimed |
| WO-1993003033-A1 | CARBONATE-SUBSTITUTED IMIDAZO[4,5-d] PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G. D. SEARLE & CO. (US) | 1993-02-18 | — | — | WO | claimed |
| US-5159131-A | Chromatography | UOP (US) | 1992-10-27 | — | — | US | claimed |
| EP-0353798-A2 | Treatment of gelling agents | UNILEVER N.V. (NL) | 1990-02-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058809-A1 | Compounds useful as reversible inhibitors of cysteine proteases | CTSS, CTSK, CTSB | HTR2A 4774/4885HTR2C 4787/4885HTR2B 3673/4885 |
| US-11377405-B2 | Indene composition | INTS9, IPO5, INTS6 | HTR2A 1526/4885HTR2C 450/4885HTR2B 731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.